BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 33166590)

  • 21. Identification three LncRNA prognostic signature of ovarian cancer based on genome-wide copy number variation.
    Zheng M; Hu Y; Gou R; Nie X; Li X; Liu J; Lin B
    Biomed Pharmacother; 2020 Apr; 124():109810. PubMed ID: 32000042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular Characteristics of m6A Regulators and Tumor Microenvironment Infiltration in Soft Tissue Sarcoma: A Gene-Based Study.
    Xiao KW; Yang ZQ; Yan X; Liu ZB; Yang M; Guo LY; Cai L
    Front Bioeng Biotechnol; 2022; 10():846812. PubMed ID: 35519620
    [No Abstract]   [Full Text] [Related]  

  • 23. Correlative Study on the Relationship between the Expression of m6a-Related Genes and the Prognosis and Immunotherapy of Soft Tissue Sarcoma.
    Qiu Y; Li J; Yao J; Meng J; Huang X; Zheng X; Wen Z; Huang J; Wang H
    Biomed Res Int; 2022; 2022():5439023. PubMed ID: 38024481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deconvolution of sarcoma methylomes reveals varying degrees of immune cell infiltrates with association to genomic aberrations.
    Simon M; Mughal SS; Horak P; Uhrig S; Buchloh J; Aybey B; Stenzinger A; Glimm H; Fröhling S; Brors B; Imbusch CD
    J Transl Med; 2021 May; 19(1):204. PubMed ID: 33980253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PD-L1 (CD274) copy number gain, expression, and immune cell infiltration as candidate predictors for response to immune checkpoint inhibitors in soft-tissue sarcoma.
    Budczies J; Mechtersheimer G; Denkert C; Klauschen F; Mughal SS; Chudasama P; Bockmayr M; Jöhrens K; Endris V; Lier A; Lasitschka F; Penzel R; Dietel M; Brors B; Gröschel S; Glimm H; Schirmacher P; Renner M; Fröhling S; Stenzinger A
    Oncoimmunology; 2017; 6(3):e1279777. PubMed ID: 28405504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncopig Soft-Tissue Sarcomas Recapitulate Key Transcriptional Features of Human Sarcomas.
    Schachtschneider KM; Liu Y; Mäkeläinen S; Madsen O; Rund LA; Groenen MAM; Schook LB
    Sci Rep; 2017 Jun; 7(1):2624. PubMed ID: 28572589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic Value of a Three-DNA Methylation Biomarker in Patients with Soft Tissue Sarcoma.
    Chen Y; Zhu R; Chen M; Guo W; Yang X; Xu XJ; Zhu L
    J Oncol; 2020; 2020():8106212. PubMed ID: 32508922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Establishment and molecular characterisation of seven novel soft-tissue sarcoma cell lines.
    Salawu A; Fernando M; Hughes D; Reed MW; Woll P; Greaves C; Day C; Alhajimohammed M; Sisley K
    Br J Cancer; 2016 Oct; 115(9):1058-1068. PubMed ID: 27560552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrative DNA methylation and gene expression analysis in high-grade soft tissue sarcomas.
    Renner M; Wolf T; Meyer H; Hartmann W; Penzel R; Ulrich A; Lehner B; Hovestadt V; Czwan E; Egerer G; Schmitt T; Alldinger I; Renker EK; Ehemann V; Eils R; Wardelmann E; Büttner R; Lichter P; Brors B; Schirmacher P; Mechtersheimer G
    Genome Biol; 2013 Dec; 14(12):r137. PubMed ID: 24345474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of p16(INK4a) is associated with reduced patient survival in soft tissue tumours, and indicates a senescence barrier.
    Knösel T; Altendorf-Hofmann A; Lindner L; Issels R; Hermeking H; Schuebbe G; Gibis S; Siemens H; Kampmann E; Kirchner T
    J Clin Pathol; 2014 Jul; 67(7):592-8. PubMed ID: 24747207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting Fibroblast Growth Factor Receptor 1 for Treatment of Soft-Tissue Sarcoma.
    Chudasama P; Renner M; Straub M; Mughal SS; Hutter B; Kosaloglu Z; Schweßinger R; Scheffler M; Alldinger I; Schimmack S; Persigehl T; Kobe C; Jäger D; von Kalle C; Schirmacher P; Beckhaus MK; Wolf S; Heining C; Gröschel S; Wolf J; Brors B; Weichert W; Glimm H; Scholl C; Mechtersheimer G; Specht K; Fröhling S
    Clin Cancer Res; 2017 Feb; 23(4):962-973. PubMed ID: 27535980
    [No Abstract]   [Full Text] [Related]  

  • 32. Prospective Evaluation of the Concordance of Commercial Circulating Tumor DNA Alterations with Tumor-Based Sequencing across Multiple Soft Tissue Sarcoma Subtypes.
    Demoret B; Gregg J; Liebner DA; Tinoco G; Lenobel S; Chen JL
    Cancers (Basel); 2019 Nov; 11(12):. PubMed ID: 31766329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A clinico-genomic analysis of soft tissue sarcoma patients reveals CDKN2A deletion as a biomarker for poor prognosis.
    Bui NQ; Przybyl J; Trabucco SE; Frampton G; Hastie T; van de Rijn M; Ganjoo KN
    Clin Sarcoma Res; 2019; 9():12. PubMed ID: 31528332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Prognostic Value of m6A RNA Methylation Regulators in Colon Adenocarcinoma.
    Liu T; Li C; Jin L; Li C; Wang L
    Med Sci Monit; 2019 Dec; 25():9435-9445. PubMed ID: 31823961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soft tissue sarcoma subtypes exhibit distinct patterns of acquired uniparental disomy.
    Tuna M; Ju Z; Amos CI; Mills GB
    BMC Med Genomics; 2012 Dec; 5():60. PubMed ID: 23217126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene signatures and prognostic values of m6A regulators in clear cell renal cell carcinoma - a retrospective study using TCGA database.
    Zhou J; Wang J; Hong B; Ma K; Xie H; Li L; Zhang K; Zhou B; Cai L; Gong K
    Aging (Albany NY); 2019 Mar; 11(6):1633-1647. PubMed ID: 30877265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Case Series of Soft Tissue Sarcoma Patients with Brain Metastasis with Implications from Genomic and Transcriptomic Analysis.
    Park C; Kim R; Choi J; Kim M; Kim TM; Han I; Kim JI; Kim HS
    Cancer Res Treat; 2024 Apr; 56(2):665-674. PubMed ID: 37752792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and validation of novel prognostic models for zinc finger proteins-related genes in soft tissue sarcoma.
    Li J; Zhou Q; Zhang C; Zhu H; Yao J; Zhang M
    Aging (Albany NY); 2023 Apr; 15(8):3171-3190. PubMed ID: 37100454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathological characteristics and prognostic factors of T1 (≤5 cm) soft tissue sarcoma -- a comparative study with T2 (>5 cm) soft tissue sarcoma.
    Kang S; Han I; Lee S; Kim W; Kim H
    Eur J Surg Oncol; 2014 Apr; 40(4):406-11. PubMed ID: 24388741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced mitochondrial DNA copy number in peripheral blood leukocytes increases the risk of soft tissue sarcoma.
    Xie H; Lev D; Gong Y; Wang S; Pollock RE; Wu X; Gu J
    Carcinogenesis; 2013 May; 34(5):1039-43. PubMed ID: 23349016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.